Beck Bode’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Beck Bode's ASND Position: Q1 2026 in Review
Beck Bode sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 81,087 shares — an estimated $17.3M sold.
Beck Bode first reported a position in ASND in Q4 2025 and held it in 1 quarter. The position peaked at $17.3M in Q4 2025. 277 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- Beck Bode reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
- Beck Bode sold 81,087 Ascendis Pharma A/S shares in Q1 2026, an estimated $17.3M.
- Beck Bode first reported a position in Ascendis Pharma A/S in Q4 2025 and held it in 1 quarter.
- Beck Bode's Ascendis Pharma A/S position peaked at $17.3M in Q4 2025.
- 277 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.
Based on Beck Bode's 13F filing for Q1 2026, filed 7 May 2026.